Long-Term Outcome of Patients with Chronic Thromboembolic Pulmonary Hypertension : Results from an International Prospective Registry

Circulation

Volumn 133, Issue 9, 2016, Pages 859-871

  Delcroix, Marion ^a   Lang, Irene ^b   Pepke Zaba, Joanna ^c   Jansa, Pavel ^d   D'Armini, Andrea M ^e   Snijder, Repke ^f   Bresser, Paul ^g   Torbicki, Adam ^h   Mellemkjaer, Sören ⁱ   Lewczuk, Jerzy ^j   Simkova, Iveta ^k   Barberà, Joan A ^l   De Perrot, Marc ^m   Hoeper, Marius M ^n,o   Gaine, Sean ^p   Speich, Rudolf ^q   Gomez Sanchez, Miguel A ^r   Kovacs, Gabor ^s   Jais, Xavier ^t   Ambroz, David ^d   Treacy, Carmen ^c   Morsolini, Marco ^e   Jenkins, David ^c   Lindner, Jaroslav ^d   Dartevelle, Philippe ^t   Mayer, Eckhard ^u   Simonneau, Gérald ^t   more..

^a UNIVERSITY OF LEUVEN   (Belgium)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c PAPWORTH HOSPITAL   (United Kingdom)

^d CHARLES UNIVERSITY   (Czech Republic)

^e UNIVERSITY OF PAVIA   (Italy)

^f ST ANTONIUS HOSPITAL   (Netherlands)

^g ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^h Department of Orthopaedics   (Poland)

ⁱ AARHUS UNIVERSITY HOSPITAL   (Denmark)

^j WROCLAW MEDICAL UNIVERSITY   (Poland)

^k SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^l UNIVERSITY OF BARCELONA   (Spain)

^m TORONTO GENERAL HOSPITAL   (Canada)

ⁿ HANNOVER MEDICAL SCHOOL   (Germany)

^o German Centre for Lung Research   (Germany)

^p MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^q UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^r INSTITUTO DE SALUD CARLOS III   (Spain)

^s MEDICAL UNIVERSITY OF GRAZ   (Austria)

^t UNIVERSITÉ PARIS SACLAY   (France)

^u MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

more..

Author keywords

Endarterectomy; hypertension, pulmonary; pulmonary embolism; survival; thromboembolism

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART RIGHT ATRIUM PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REGISTER; SURVIVAL; ADOLESCENT; CHRONIC DISEASE; CLINICAL TRIAL; HYPERTENSION, PULMONARY; INTERNATIONAL COOPERATION; MIDDLE AGED; PULMONARY EMBOLISM; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INTERNATIONALITY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; REGISTRIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84959480777     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.016522     Document Type: Article

References (33)

1. Lang IM, Pesavento R, Bonderman D, Yuan JX. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013;41:462-468. doi: 10.1183/09031936.00049312.
2. Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, Treacy C, D'Armini AM, Morsolini M, Snijder R, Bresser P, Torbicki A, Kristensen B, Lewczuk J, Simkova I, BarberJA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Hamid AM, Ja X, Simonneau G. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011;124:1973-1981. doi: 10.1161/CIRCULATIONAHA.110.015008.
3. Lang IM, Simonneau G, Pepke-Zaba JW, Mayer E, Ambrož D, Blanco I, Torbicki A, Mellemkjaer S, Yaici A, Delcroix M. Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study. Thromb Haemost. 2013;110:83-91. doi: 10.1160/TH13-02-0097.
4. Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, Channick RN, Fedullo PF, Auger WR. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76:1457-62; discussion 1462.
5. Ja X, D'Armini AM, Jansa P, Torbicki A, Delcroix M, Ghofrani HA, Hoeper MM, Lang IM, Mayer E, Pepke-Zaba J, Perchenet L, Morganti A, Simonneau G, Rubin LJ; Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension Study Group. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebocontrolled trial. J Am Coll Cardiol. 2008;52:2127-2134. doi: 10.1016/j. jacc.2008.08.059.
6. Ghofrani HA, D'Armini AM, Grimminger F, Hoeper MM, Jansa P, Kim NH, Mayer E, Simonneau G, Wilkins MR, Fritsch A, Neuser D, Weimann G, Wang C; CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369:319-329. doi: 10.1056/NEJMoa1209657.
7. Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, Lang I, Madani MM, Ogino H, Pengo V, Mayer E. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 suppl):D92-D99. doi: 10.1016/j.jacc.2013.10.024.
8. Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, Kapelanski DP, Watt CN, Moser KM. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999;160:523-528. doi: 10.1164/ajrccm.160.2.9808109.
9. Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, Hodgkins D, Goldsmith K, Hughes RJ, Sheares K, Tsui SS, Armstrong IJ, Torpy C, Crackett R, Carlin CM, Das C, Coghlan JG, Pepke-Zaba J. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177:1122-1127. doi: 10.1164/rccm.200712-1841OC.
10. Skoro-Sajer N, Marta G, Gerges C, Hlavin G, Nierlich P, Taghavi S, Sadushi-Kolici R, Klepetko W, Lang IM. Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy. Thorax. 2014;69:116-122. doi: 10.1136/thoraxjnl-2013-203746.
11. Matsuda H, Ogino H, Minatoya K, Sasaki H, Nakanishi N, Kyotani S, Kobayashi J, Yagihara T, Kitamura S. Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 2006;82:1338-1343; discussion 1343. doi: 10.1016/j.athoracsur.2006.03.105.
12. Corsico AG, D'Armini AM, Cerveri I, Klersy C, Ansaldo E, Niniano R, Gatto E, Monterosso C, Morsolini M, Nicolardi S, Tramontin C, Pozzi E, ViganM. Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med. 2008;178:419-424. doi: 10.1164/rccm.200801-101OC.
13. Saouti N, Morshuis WJ, Heijmen RH, Snijder RJ. Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a single institution experience. Eur J Cardiothorac Surg. 2009;35:947-952; discussion 952. doi: 10.1016/j. ejcts.2009.01.023.
14. Wieteska M, Biederman A, Kurzyna M, Dyk W, Burakowski J, Wawrzyska L, Szturmowicz M, Fijakowska A, Szatkowski P, Torbicki A. Outcome of medically versus surgically treated patients with chronic thromboembolic pulmonary hypertension. Clin Appl Thromb Hemost. 2016;22:92-99. doi: 10.1177/1076029614536604.
15. D'Armini AM, Morsolini M, Mattiucci G, Grazioli V, Pin M, Valentini A, Silvaggio G, Klersy C, Dore R. Pulmonary endarterectomy for distal chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2014;148:1005-1011; 1012.e1. doi: 10.1016/j. jtcvs.2014.06.052.
16. Nagaya N, Sasaki N, Ando M, Ogino H, Sakamaki F, Kyotani S, Nakanishi N. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest. 2003;123:338-343.
17. Bresser P, Fedullo PF, Auger WR, Channick RN, Robbins IM, Kerr KM, Jamieson SW, Rubin LJ. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004;23:595-600.
18. Reesink HJ, Surie S, Kloek JJ, Tan HL, Tepaske R, Fedullo PF, Bresser P. Bosentan as a bridge to pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2010;139:85-91. doi: 10.1016/j.jtcvs.2009.03.053.
19. Jensen KW, Kerr KM, Fedullo PF, Kim NH, Test VJ, Ben-Yehuda O, Auger WR. Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation. 2009;120:1248-1254. doi: 10.1161/CIRCULATIONAHA.109.865881.
20. Cabrol S, Souza R, Jais X, Fadel E, Ali RH, Humbert M, Dartevelle P, Simonneau G, Sitbon O. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2007;26:357-362. doi: 10.1016/j.healun.2006.12.014.
21. Skoro-Sajer N, Bonderman D, Wiesbauer F, Harja E, Jakowitsch J, Klepetko W, Kneussl MP, Lang IM. Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2007;5:483-489. doi: 10.1111/j.1538-7836.2007.02394.x.
22. Suntharalingam J, Machado RD, Sharples LD, Toshner MR, Sheares KK, Hughes RJ, Jenkins DP, Trembath RC, Morrell NW, Pepke-Zaba J. Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension. Thorax. 2007;62:617-622. doi: 10.1136/thx.2006.070680.
23. Saouti N, de Man F, Westerhof N, Boonstra A, Twisk J, Postmus PE, Vonk Noordegraaf A. Predictors of mortality in inoperable chronic thromboembolic pulmonary hypertension. Respir Med. 2009;103:1013-1019. doi: 10.1016/j.rmed.2009.01.017.
24. Scholzel BE, Post MC, Thijs Plokker HW, Snijder RJ. Clinical worsening during long-term follow-up in inoperable chronic thromboembolic pulmonary hypertension. Lung. 2012;190:161-167. doi: 10.1007/s00408-011-9350-z.
25. Lewczuk J, Piszko P, Jagas J, Porada A, Wciak S, Sobkowicz B, Wrabec K. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest. 2001;119:818-823.
26. Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982;81:151-158.
27. Mayer E, Jenkins D, Lindner J, D'Armini A, Kloek J, Meyns B, Ilkjaer LB, Klepetko W, Delcroix M, Lang I, Pepke-Zaba J, Simonneau G, Dartevelle P. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141:702-710. doi: 10.1016/j.jtcvs.2010.11.024.
28. GaliN, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J; Task Force. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J. 2004;25:2243-2278. doi: 10.1016/j.ehj.2004.09.014.
29. Bonderman D, Wilkens H, Wakounig S, Schers HJ, Jansa P, Lindner J, Simkova I, Martischnig AM, Dudczak J, Sadushi R, Skoro-Sajer N, Klepetko W, Lang IM. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009;33:325-331. doi: 10.1183/09031936.00087608.
30. Jenkins DP, Madani M, Mayer E, Kerr K, Kim N, Klepetko W, Morsolini M, Dartevelle P. Surgical treatment of chronic thromboembolic pulmonary hypertension. Eur Respir J. 2013;41:735-742. doi: 10.1183/09031936.00058112.
31. Arbustini E, Morbini P, D'Armini AM, Repetto A, Minzioni G, Piovella F, ViganM, Tavazzi L. Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Heart. 2002;88:177-182.
32. Lang IM, Madani M. Update on chronic thromboembolic pulmonary hypertension. Circulation. 2014;130:508-518. doi: 10.1161/CIRCULATIONAHA.114.009309.
33. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yai A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Ja X, Montani D, Souza R, Simonneau G. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010;122:156-163. doi: 10.1161/CIRCULATIONAHA.109.911818.